Essity B 275 (-0.1 SEK) on 05-Jul-2022 17:29
Select region

Global Site

USA USA Russia Russia Germany Germany Mexico Mexico Netherlands Netherlands France France Sweden Sweden Italy Italy Spain Spain
Essity logo
Brands

Company

Essity at a Glance
Purpose and Vision Our Beliefs Our History
Business Areas
Health & Medical Consumer Goods Professional Hygiene Market and Trends Market Positions E-Commerce
Breaking Barriers to Well-being
Stories Partnerships Insights Events
Diversity, Equity and Inclusion
Strategy
Our Business Model Our Strategic Priorities
Organization and Management
Board of Directors CEO and EVP Business and Global Units Management Group Functions
Corporate Governance
Articles of Association General Meeting Nomination Committee Auditors Board and Committee Work Remuneration to the Board of Directors Remuneration Policy Public Policies Sustainability Governance
Risk Management
Essity in the World

Brands

Sustainability

What We Do
How We Do It
Responsible Sourcing Resource-efficient Production Responsible Business Responsible Marketing
Why We Do It
Sustainable Development Goals Science Based Targets
Our Journey to Net zero
Key Action Areas Climate targets
Role in Society
Partnerships and Collaborations Essity in the Spotlight Ways of Working Trade Associations and Policy Organizations Public Policy Development Positions Advancing the Knowledge
Human Rights
Community Relations
Reporting and Data
Annual and Sustainablity Report Sustainability in Brief Essity Non-financial Reporting System Environmental Data Certification
Recognitions and Ratings
Contact Us

Innovation

Products and Solutions
Digitalization
Essity Ventures
Latest Innovations

Careers

Job Opportunities
Work at Essity
Commitment to Our Employees Diversity, Equity and Inclusion Learning and Development Why Choose Essity?
Students and Graduates
Graduates Students Internships Apprenticeships
Life at Essity
Women in IT Career Stories
Alumni Network
Connect with Us
Career Events
Total Rewards

Investors

Essity as an Investment
Targets and Outcomes
Essity Share
Data per Share Ownership Dividend List of Analysts Trade Information Share Conversion Share Capital Development Indexes
Financials
Reports
Interim Reports Annual Reports Prospectus
Presentations and Webcasts
Capital Markets Day 2021
Investor Day 2019
Debt Financing
Debt Programmes Credit Rating Funding Sources Key Debt Ratios
Essity Data
Acquisitions and Divestments
Investor Relations Calendar
Investor Relations Contacts
Subscribe

Media

Press Releases
News Features
Images & Video
Subscribe
Media Contact
Local Media Contacts
Essity in Social Media
Home
Media
Press releases
2021
Media
Press Releases News Features Images & Video Subscribe Media Contact Essity in Social Media

December 29, 2021

Essity acquires advanced wound care company in US

Hygiene and health company Essity has acquired the company Hydrofera. The company offers technology and products within advanced wound care. The purchase price amounts to USD 116m (approximately SEK 1.1bn) with a potential additional earnout amount of USD 15m (approximately SEK 137m) on a cash and debt free basis. The acquisition supports Essity’s strategic priority to grow through acquisitions in Medical Solutions.

The US company Hydrofera was founded in 1996 and is a developer of Hydrofera Blue Antibacterial Wound Dressings, an advanced line of wound care products designed to shorten healing times, lower treatment costs, and deliver better patient outcomes. The company, which has about 90 employees, has its head office in Manchester, Connecticut and is present in more than 15 countries. 

For the first nine months of 2021, Hydrofera reported net sales of USD 20.7m (SEK 176m) with an EBITDA of USD 5,9m (SEK 50m), an EBITA of USD 5,6m (SEK 48m), equivalent to an EBITA margin of 27.2%. Sales growth for the first nine months of 2021 amounted to 22%. In 2020, the company reported net sales of approximately USD 23.5m (SEK 216m), with an EBITDA of USD 4.6m (SEK 42m) and EBITA of USD 4.3m (SEK 39m), equivalent to an EBITA margin of 18.1%. Sales growth in 2020 amounted to 13%. The acquisition is expected to be accretive to Essity’s earnings per share in 2022.  

“The acquisition of Hydrofera is yet another great strategic fit for Essity further strengthening our innovation capacity and expanding our offering within advanced wound care. The company has innovations that significantly accelerate healing and reduce the patient's discomfort,” says Ulrika Kolsrud, President Health and Medical Solutions at Essity. 

Hydrofera has a direct sales force and maintains agreements and preferred provider status with the major national medical/surgical distributors and buying groups in the US and Canadian healthcare markets. Products are used across the entire care range such as hospitals, wound clinics, long term care facilities and homecare. The suite of products is designed to meet requirements for a wide variety of wound care needs. 

Essity’s medical solutions business offers innovative and high-quality medical products in wound care, compression, and orthopedics with global brands such as Leukoplast, Cutimed, JOBST, Actimove and Delta-Cast. In acute and advanced wound care, Essity is the world’s fifth largest player. 

NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 14:00 CET on December 29, 2021. 

Karl Stoltz, Media Relations Manager, +46 709 426 338

Essity acquires advanced wound care company in US
Back to press releases

Share this

Essity logo
Company Careers Brands Breaking Barriers Contact Us
Privacy Policy Cookies Terms and Conditions

Tel +46 8-788 51 00

© Essity Aktiebolag (publ). Box 200, SE-101 23, Stockholm, Sweden